Keywords: 4th, qtr/year-end, results, see, strong, growth, among
US 4th Qtr/Year-End Results See Strong Growth
Article | 27 January 1997
Among US pharmaceutical companies reporting fourth quarter and full-yearresults for 1996, there were some exceptional figures. Pfizer, for example, saw full-year ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Aspen Pharma offers to buy GlaxoSmithKline's thrombosis brands and manufacturing site
- US Supreme Court says patent settlement can "sometimes" be illegal
- Athera and Boehringer Ingelheim enter option agreement on a novel therapy for atherosclerosis
- FDA probes two deaths possibly linked to Lilly's antipsychotic Zyprexa Relprevv
- Australia's pharma industry applauds R&D regulatory reform
